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A 34-year-old male was admitted to hospital for the suspicion of pulmonary tuberculosis. He underwent
haematological investigations and radiological tests which were compatible with this diagnosis.
However, the lack of microbiological conﬁrmation together with the rapid deterioration of clinical,
radiological and functional status led towards the diagnosis of Wegener’s granulomatosis. A computed
tomographic guided biopsy and cytoplasmic antineutrophil cytoplasmic antibody test proved this
positive. In an area where the incidence of tuberculosis is the highest in Europe, it should be emphasised
that not all patients presenting with haemoptysis and foreign travel should be assumed to have
tuberculosis.
Crown Copyright  2009 Published by Elsevier Ltd. All rights reserved.Case report
A 34-year-old male jeweller presented to accident and emer-
gency department complaining of shortness of breath, fever and
weight loss of 5 kg despite normal appetite. He complained of night
sweats and shivering. The morning of attendance, he had an
episode of a productive coughwith dark red phlegm. His symptoms
started one month ago on arrival to this country fromMauritius. He
had no history of unprotected sex, blood transfusions, or HIV/Hep B
or known contact with tuberculosis. He also has had no gastroin-
testinal or genitourinary disturbances. He is a non-smoker and
a non-drinker. On clinical examination, the patient was hyper-
ventilating (respiratory rate 45), with reduced air entry left base as
well as right base andmid zone of both lungs. The right base of lung
was dull to percussion. He had a short expiratory wheeze in the
right lung throughout. There was no evidence of any lymphade-
nopathy. Arterial blood gas showed respiratory alkalosis. It was
noted that Two Bacillus Calmette-Gue´rin vaccination scars were
present on the left arm. Chest X-ray revealed ‘non-homogenous
consolidation in the right lower zone associated with pleural
effusion. Small patchy nodular shadows are seenmid zones on both
sides. The hili and left costophrenic angles are clear (Fig. 1). The
radiologist suggested ‘repeat radiograph after a course of antibi-
otics/further evaluation for tuberculosis (TB)’. A differential diag-
nosis of pulmonary TB or community acquired pneumonia wase, Middlesex UB6 7DP, UK.
adad).
d by Elsevier Ltd. All rights reservegiven. The tachypnoea was thought to be anxiety based from the
appearance of blood in his expectoration. His haematological
parameters including D-dimer were otherwise normal apart from
mild microcytic anaemia (Hb 12.4, MCV 73) and raised C reactive
protein of 31 mg/l (Normal< 10). Sputum was sent for acid fast
bacilli and culture. The patient was isolated on the ward and no
further evidence of haemoptysis occurred. He remained afebrile
but had signs of tachycardia and tachypnoea over the next 5 days.
He had a Mantoux test and underwent bronchoscopy where ﬁnd-
ings included erythema of the right upper lung. Samples were sent
for culture and sensitivity, acid fast bacilli as well as fungal staining
and cytology. Autoimmune haematological tests were also ana-
lysed. The patient underwent a Computed tomography (CT) guided
biopsy and this showed multiple bilateral nodular opacities (Fig. 2).
The report mentioned the ‘differential is varied but would include
infection, such as TB or other bacterial pathogens, Sarcoid is also
possible. Malignancy is less likely but cannot be totally excluded.’
As the symptoms remained the same over this period, he was sent
home pending results of these investigations. He represented to
accident and emergency 3 days later, with tachypnoea (rate of 55)
and tachycardia (133 bpm) and oxygen saturation of 78% on room
air. He complained of an increase in frequency and amount of blood
being coughed. He expressed that he had coughed up to half a cup
of blood. He had also developed pain in legs and arms 2 days earlier.
On clinical exam the left lung base was now dull to percussion and
vesicular breathing prominent mostly in the left lung. There were
also coarse crackles bilaterally, being greater in the left than the
right lung. A chest X-ray was repeated and this showed ‘bilateral
airspace shadowing seen involving the mid and lower zones’
(Fig. 3). Here, the differential was an ‘infection secondary tod.
Fig. 1. Non-homogenous consolidation is seen in the right lower zone associated with
pleural effusion. Small patchy nodular shadows are seen mid zones on both sides. The
hili and left costo phrenic angles are free.
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showed WBC 12.1, CRP 44.5. Heart echocardiograph showed
‘dilated left atria, rheumatic mitral valve with moderate stenosis;
MVA 1.3 cm. There is minimal calciﬁcation and no vegetation.’ He
also underwent a pleural tap where 23 ml of ﬂuid was aspirated
from the left lung and sent for laboratory analysis. Cytology from
bronchi showed ‘mixed inﬂammatory cells’. The patient’s labora-
tory results were Legionella negative as well as mycology culture
and sensitivity negative. Urine dip for blood and acid fast bacilli
were negative. He continued to deteriorate with regards to theFig. 2. There are multiple patchy nodular opacities bilaterally. The nodules are in fact
areas of consolidation which contain air bronchograms. No mediastinal adenopathy is
seen. No bony lesion seen. Only the upper abdomen was scanned and there is a small
amount of ﬂuid in the gallbladder bed. It may be worth considering performing and
ultrasound of the abdomen to clarify. Conclusion: multiple bilateral nodular opacities.
The differential is wide but would include infection, such as TB or other bacterial
pathogens. Sarcoid is also possible. I think malignancy is less likely but cannot be
totally excluded.tachycardia and tachypnoea. Haematological investigations
showed Hb 8.9, WBC 16.7, MCV 13.3, C reactive protein 143.3 mg/l.
By now, he had been transferred to the high dependency unit
(HDU) for respiratory support and continuous positive airway
pressure. The CT guided Lung biopsy gave a diagnosis of Wegener’s
granulomatosis and blood test was positive for ANCAþ PR-3>100.
At this point, his urine had a red cell count of 230 and had þþ casts
present. Patient was started on methylprednisolone, tranexamic
acid and antibiotics. He was also started on anti-TB regime. He
remained in HDU for 1 week before going back to the ward. He also
had 1 unit of blood due to the low Hb. The patient was reviewed by
the renal team and started on Cyclophosphamide. He was dis-
charged 5 days later. His review in clinic 2 weeks later showed
improvement in his signs and symptoms and on his most recent
review, the respiratory signs and symptoms have resolved.Discussion
Wegener’s granulomatosis (WG) is a systemic necrotising
granulomatous inﬂammatory condition that may be accompanied
by vasculitis, classically involving the upper respiratory tract, lungs,
and kidneys.1 Vasculitis can be categorised by the size of vessel
affected (small, medium, or large). It was ﬁrst described by Klinger
and Rossle in 1933, followed byWegener himself in 1936 and 1939,
and Ringertz in 1947.2 The clinical presentation of WG can be so
diverse that the list of differential diagnoses is vast, ranging from
infections (fungal, bacterial, and mycobacterial) to other vasculit-
ides, including Henoch- Scho¨ nlein purpura, sarcoidosis, Behcet
syndrome, and malignancies.3 Unexplained constitutional symp-
toms are often part of the initial presentation.4 The disease affects
a wide age range, with a peak incidence in middle age, with a male
to female ratio of 3:2. If left untreated the disease can be fatal with
the need for early diagnosis and treatment to prevent renal failure,
which is the most common cause of death.5 Untreated WG has
a poor prognosis, with most patients dying within two years. With
cytotoxic treatment, this has improved, and the eight-year survival
is about 80%.6 Up to 90% of patients respond to cyclophosphamide,
and three quarters have a complete remission.7 Induction treat-
ment is usually given as combined treatment with cyclophospha-
mide and corticosteroids. Patients with severe disease are treatedFig. 3. Shadowing seen involving the mid and lower zones and is progressing
compared to the previous chest X-ray done. Features could be due to multifocal
infection or pulmonary oedema.
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nisolone. The mean time to complete remission is 12 months, with
occasional patients requiring treatment for more than 2 years
before all symptoms have resolved. Therefore, patients should not
be considered non-responders until they have been monitored on
this regimen for more than several months. Other therapies for WG
include methotrexate and prednisone, which is another alternative
for patients with active but not immediately life threatening
disease and normal or near-normal renal function.8 A limited form
involving the upper respiratory tract has been described in
a quarter of cases. The most common presenting symptoms include
most upper airway respiratory symptoms, but particularly rhinor-
rhoea, oral ulcers, nasal discharge, polyarthralgias, myalgias, and
sinus pain. Lower airway complaints such as cough, dyspnoea,
haemoptysis, and pleuritic pain are also early features (Involve-
ment of lungs has been reported in up to 94% of patients).9 More
rarely, WG can present with tumour-like masses distant from the
lung. The renal disease often presents with haematuria, red cell
casts, proteinuria, and renal failure. Patients may present to the
clinician with pulmonary symptoms only, and chest radiographs
may show ill-deﬁned nodules, often bilateral, resulting in the
differential diagnosis of malignancy.10 Sputum cytology, trans-
bronchial biopsy, or ﬁne needle aspiration cytology can aid diag-
nosis as was done in our case. Open lung biopsy is, however, usually
necessary for the deﬁnitive diagnosis of pulmonary WG.11 Positive
results for the serummarker ANCA have been obtained for patients
with WG, with an overall sensitivity of 85–90% and speciﬁcity of
90% for active disease. There is a strong and speciﬁc association
with autoantibodies directed against proteinase 3, a constituent of
neutrophil azurophilic granules.12 These may suggest Wegener’s
granulomatosis in patients with atypical presentations. The pres-
ence of such antibodies is a strong indicator for a diagnosis of WG,
but should not be used in place of a tissue diagnosis. Occasionally,
patients with infections, neoplasms, inﬂammatory bowel disease,
sclerosing cholangitis and other rheumatologic diseases develop
ANCA, but these are predominantly perinuclear ANCAs or exhibit
an atypical staining pattern.13 Because the patient had only
pulmonary disease in the initial stages and the radiology was also
suggestive of TB, WGwas not considered. This was compounded by
the fact that the cytoplasmic ANCA titres, which have a high
sensitivity and speciﬁcity in cases of active. Wegener’s gran-
ulomatosis were not performed until later and take a few days for
laboratory conﬁrmation. This led to a delay in diagnosis. This cases
emphasise that WG must be considered when assessing multiple
pulmonary lesions in the absence of other clinical signs. Close
communication between the cytopathologist and the clinician is
essential to avoid incorrect diagnosis in the presence of inconclu-
sive cytological test results. This is necessary to ensure that WG is
diagnosed early so that lifesaving treatment can be started
promptly.1
This case stresses the need of fully investigate patients that
present with TB like symptoms.It is essential to exclude myco-
bacterial infection before making a diagnosis of WG due to the
overlapping clinical and histological features of these diseases.Even so, a diagnosis of WG does not exclude tuberculosis and vice
versa, and failure to respond to treatment should cause suspicion.
A ﬁrm diagnosis of mycobacterial infection depends on the
detection of acid fast bacilli and positive cultures. It is well
recognized that this may be difﬁcult to establish, and it is impor-
tant that fresh specimens of potential lesions are sent for bacte-
riological examination and culture in all cases of granulomatous
disease, irrespective of the other ﬁndings. As an infection may
trigger WG, and both WG and immunosuppressive therapy will
compromise immune function, infection (including opportunistic
organisms) should be sought routinely in patients with WG who
deteriorate.14 These patients should also undergo an ophthalmo-
logic examination as an important part of the diagnostic evalua-
tion. Any compartment of the eye may be affected with visual loss
reported in as many as 8% of patients. Other unusual presentations
of WG include salivary gland, cutaneous, gastrointestinal, and
cardiac involvement.6 Our patient responded to cyclophosphamide
therapy and steroids with marked improvement in his inﬂamma-
tory signs and symptoms. TB or not TB? The evidence in hand
answers that question!Conﬂict of interest
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